447 related articles for article (PubMed ID: 29954411)
1. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
2. Epidermal Growth Factor Receptor Expression in Spindle Cell Carcinomas of the Head and Neck.
Watson RF; Chernock RD; Zhang KH; Michel LS; Adkins DR; El-Mofty SK; Lewis JS
Head Neck Pathol; 2015 Sep; 9(3):360-8. PubMed ID: 25563452
[TBL] [Abstract][Full Text] [Related]
3. Immunoscoring of epidermal growth factor receptor expression in recurrent cases of oral squamous cell carcinoma.
Mehta A; Chowdhary M; Sinha R
J Oral Pathol Med; 2015 Nov; 44(10):818-22. PubMed ID: 25581523
[TBL] [Abstract][Full Text] [Related]
4. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance.
Hashmi AA; Hussain ZF; Hashmi SK; Irfan M; Khan EY; Faridi N; Khan A; Edhi MM
BMC Res Notes; 2018 Jul; 11(1):433. PubMed ID: 29970180
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemistry study of EGFR expression in head and neck squamous cell carcinoma].
Altuna Mariezkurrena X; Algaba Guimerá J; Wang Rodríguez J; Weisman R; Ongkeko W
Acta Otorrinolaringol Esp; 2005 Apr; 56(4):143-6. PubMed ID: 15871288
[TBL] [Abstract][Full Text] [Related]
8. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
[TBL] [Abstract][Full Text] [Related]
9. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
10. The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx.
Şimşek H; Han Ü; Önal B; Şimişek G
Turk J Med Sci; 2014; 44(3):411-6. PubMed ID: 25558642
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma.
Zafar M; Hashmi SN; Faisal MJ; Ahmed R; Ali SS
J Coll Physicians Surg Pak; 2017 Apr; 27(4):209-212. PubMed ID: 28492148
[TBL] [Abstract][Full Text] [Related]
12. Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma.
Chung CH; Zhang Q; Hammond EM; Trotti AM; Wang H; Spencer S; Zhang HZ; Cooper J; Jordan R; Rotman MH; Ang KK
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):331-8. PubMed ID: 20732768
[TBL] [Abstract][Full Text] [Related]
13. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
[TBL] [Abstract][Full Text] [Related]
14. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
Bădulescu F; Bădulescu A; Crişan A; Popescu FC
Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cells.
Ansell A; Jedlinski A; Johansson AC; Roberg K
J Oral Pathol Med; 2016 Jan; 45(1):9-16. PubMed ID: 25677871
[TBL] [Abstract][Full Text] [Related]
16. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.
Husain H; Psyrri A; Markovic A; Rampias T; Pectasides E; Wang H; Slebos R; Yarbrough WG; Burtness B; Chung CH
Laryngoscope; 2012 Dec; 122(12):2762-8. PubMed ID: 23086695
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.
Nijkamp MM; Span PN; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende PL; de Jong M; van der Kogel AJ; Bussink J; Kaanders JH
Eur J Cancer; 2013 Oct; 49(15):3202-9. PubMed ID: 23867129
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicentre immunohistochemical study in the Asia-Pacific region.
Putti TC; To KF; Hsu HC; Chan AT; Lai GM; Tse G; Lee YS; Whang-Peng J; Millward M; Lin L; Lin X; Lee CS
Histopathology; 2002 Aug; 41(2):144-51. PubMed ID: 12147092
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Receptor (EGFR) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of Head and Neck Squamous Cell Carcinomas.
Cimpean AM; Balica RA; Doros IC; Balica NC; Gaje PN; Popovici RA; Raica M
Cancer Genomics Proteomics; 2016; 13(1):75-81. PubMed ID: 26708602
[TBL] [Abstract][Full Text] [Related]
20. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
